Targeting cytochrome bd as an anti-biofilm strategy
靶向细胞色素 bd 作为抗生物膜策略
基本信息
- 批准号:10642243
- 负责人:
- 金额:$ 27.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-08 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAerobicAffectAffinityAnaerobic BacteriaAntibiotic TherapyAntibioticsArchitectureAttenuatedBacteriaBacterial InfectionsBiologyBladderCatheterizationCathetersCell RespirationCellsCelluloseChemicalsChemosensitizationCodeCollaborationsComplexCytochromesCytosolDefectEffectivenessEnvironmentEpithelial CellsEpitheliumEscherichia coliExhibitsExtracellular MatrixGenesGoalsGrowthHemeHypoxiaImpairmentIn VitroIndividualInfectionInfective cystitisInnate Immune ResponseInvadedLinkMembraneMembrane PotentialsMembrane ProteinsMicrobial BiofilmsMinimum Inhibitory Concentration measurementMitochondriaModelingMolecularMusOxidasesOxygenPathogenesisPredispositionPrevention strategyProcessProteinsProton PumpProton-Motive ForcePumpRespirationRoleSurfaceTestingTherapeuticUrinary tractUrinary tract infectionUrologic DiseasesUropathogenic E. coliVirulence FactorsWorkbacterial communitycell communitycell motilitycopper oxidasecytochrome ccytochrome c oxidaseefficacy testinginhibitorinsightmouse modelmutantnovel therapeuticsoverexpressionpathogenpreclinical evaluationpreventquinol oxidaserespiratorystress tolerancetherapeutic developmentthree dimensional structureurinary
项目摘要
SUMMARY
Significance: Urinary tract infection (UTI) is among the most prevalent urologic diseases, and it is caused
primarily by uropathogenic Escherichia coli (UPEC). Bladder infection by UPEC is characterized by a transient
intracellular stage during which bacteria invade superficial epithelial (facet) cells and divide within the cytosol to
form multicellular communities called biofilms. After replicating in the cytosol, bacteria exit the intracellular biofilm
– killing the bladder epithelial cell in the process – and disseminate to naïve facet cells or to the upper urinary
tract. While in the intracellular biofilm state, bacteria evade innate immune responses and the effects of
antibiotics. Similarly, in catheterized individuals, formation of biofilm on the catheter surface creates an additional
protective niche for UPEC, from which it can disseminate to the bladder and seed infection. The goal of this
proposal is to evaluate the potential of inhibiting biofilm by interfering with UPEC respiration.
Rationale and Hypothesis: Although UPEC are facultative anaerobes, they respire oxygen during infection in
the hypoxic bladder environment. Aerobic respiration and oxygen sensing have also been linked to the
expression of critical UPEC virulence factors. We have previously shown that aerobic respiration is essential for
UPEC to establish infection. Of the three respiratory quinol oxidases encoded by UPEC, cytochrome bd has the
highest affinity for molecular oxygen, exceeding the affinity of mitochondrial cytochrome c by 1000-fold. Deletion
of the cydABX genes that code for cytochrome bd, does not impart a growth defect in vitro, but leads to significant
alterations in UPEC biofilm architecture, leading to higher susceptibility to antibiotics in the biofilm state.
Furthermore, cydABX deletion mutants are non-motile, exhibit decreased proton motive force (pmf) and are
attenuated in a murine UTI model. Finally, deletion of cydABX results in increased expression of the low affinity
quinol oxidase cytochrome b0. We hypothesize that cytochrome bd can be chemically targeted to thwart
biofilm formation or dissemination from a pre-formed biofilm. We further posit that cytochrome bd has
a role in energizing motility. We propose two aims to test the posed hypotheses:
Aims: Aim 1 will will evaluate whether targeting of cytochrome bd using known cytochrome bd inhibitors can
enhance antibiotic effectiveness. Aim 2 will determine whether the decreased membrane potential of the
cytochrome bd mutant imparts generalized or specific effects on pmf-dependent processes and determine how
these impaired processes affect motility. Finally, using chemical inhibition of cytochrome bd we will evaluate
whether loss of cytochrome bd function impairs dissemination from the biofilm.
Impact: These studies will be the first to address the unique contribution of cytochrome bd on UPEC motility and
will determine whether targeting bacterial respiration is a viable therapeutic or prevention strategy against UTI.
总结
意义:尿路感染(UTI)是最常见的泌尿系统疾病之一,
主要由尿路致病性大肠杆菌(UPEC)引起。UPEC引起的膀胱感染的特点是短暂的
细胞内阶段,在此期间细菌侵入表面上皮(小面)细胞并在胞质溶胶内分裂,
形成称为生物膜的多细胞群落。在细胞质中复制后,细菌离开细胞内生物膜
- 在此过程中杀死膀胱上皮细胞-并传播到幼稚的小面细胞或上尿路
道。当处于细胞内生物膜状态时,细菌逃避先天免疫应答和免疫抑制剂的作用。
抗生素类似地,在导管插入的个体中,导管表面上的生物膜的形成产生额外的生物降解。
UPEC的保护性生态位,它可以传播到膀胱和种子感染。这个目标
建议是评估通过干扰UPEC呼吸来抑制生物膜的潜力。
原理和假设:虽然UPEC是兼性厌氧菌,但它们在感染过程中呼吸氧气,
缺氧的膀胱环境。有氧呼吸和氧感也与
关键UPEC毒力因子的表达。我们以前已经表明,有氧呼吸是必不可少的,
UPEC建立感染。在由UPEC编码的三种呼吸性醌醇氧化酶中,细胞色素bd具有
对分子氧的亲和力最高,超过线粒体细胞色素c的亲和力1000倍。删除
编码细胞色素bd的cydABX基因中的一个,在体外不赋予生长缺陷,但导致显著的
UPEC生物膜结构的改变,导致生物膜状态下对抗生素的敏感性更高。
此外,cydABX缺失突变体是不运动的,表现出降低的质子动力(pmf),并且是不稳定的。
在鼠UTI模型中减毒。最后,cydABX的缺失导致低亲和力的表达增加。
醌醇氧化酶细胞色素b 0。我们假设细胞色素bd可以化学靶向阻止
生物膜形成或从预形成的生物膜传播。我们进一步证明细胞色素bd具有
一种促进运动的作用。我们提出了两个目标来检验提出的假设:
目的:目的1将评价使用已知细胞色素bd抑制剂靶向细胞色素bd是否可以
提高抗生素的有效性。目的2将确定是否降低膜电位的
细胞色素bd突变体对pmf依赖性过程产生普遍或特异性影响,并确定如何
这些受损的过程影响运动性。最后,使用细胞色素bd的化学抑制,我们将评估
细胞色素BD功能的丧失是否损害了从生物膜的传播。
影响:这些研究将是第一个解决细胞色素bd对UPEC运动的独特贡献,
将确定是否针对细菌呼吸是一个可行的治疗或预防策略对尿路感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maria Hadjifrangiskou其他文献
Maria Hadjifrangiskou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maria Hadjifrangiskou', 18)}}的其他基金
How E. coli Acid Response Mechanisms Breach Colonization Resistance in the Vagina
大肠杆菌酸反应机制如何突破阴道定植抗性
- 批准号:
10657442 - 财政年份:2022
- 资助金额:
$ 27.56万 - 项目类别:
Two-component system interactions as uropathogenic Escherichia coli drug targets
作为尿路致病性大肠杆菌药物靶标的两组分系统相互作用
- 批准号:
8816807 - 财政年份:2014
- 资助金额:
$ 27.56万 - 项目类别:
Two-component system interactions as uropathogenic Escherichia coli drug targets
作为尿路致病性大肠杆菌药物靶标的两组分系统相互作用
- 批准号:
9252820 - 财政年份:2014
- 资助金额:
$ 27.56万 - 项目类别:
Two-component system interactions as uropathogenic Escherichia coli drug targets
作为尿路致病性大肠杆菌药物靶标的两组分系统相互作用
- 批准号:
9172228 - 财政年份:2014
- 资助金额:
$ 27.56万 - 项目类别:
Administration and Regulation of Activities associated with The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery
与范德比尔特泌尿感染存储库(个性化临床发现资源)相关的活动的管理和监管
- 批准号:
10022301 - 财政年份:
- 资助金额:
$ 27.56万 - 项目类别:
The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery
范德比尔特泌尿感染存储库,个性化临床发现的资源
- 批准号:
9913352 - 财政年份:
- 资助金额:
$ 27.56万 - 项目类别:
The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery
范德比尔特泌尿感染存储库,个性化临床发现的资源
- 批准号:
10022306 - 财政年份:
- 资助金额:
$ 27.56万 - 项目类别:
Administration and Regulation of Activities associated with The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery
范德比尔特泌尿感染信息库(个性化临床发现资源)相关活动的管理和监管
- 批准号:
9913351 - 财政年份:
- 资助金额:
$ 27.56万 - 项目类别:
相似海外基金
Targeting aerobic glycolysis via hexokinase 2 inhibition in Natural Killer T cell lymphomas
通过抑制己糖激酶 2 靶向自然杀伤 T 细胞淋巴瘤中的有氧糖酵解
- 批准号:
23K07830 - 财政年份:2023
- 资助金额:
$ 27.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Developing Late Metal Catalytic Systems for Aerobic Partial Oxidation of Alkanes
开发烷烃有氧部分氧化的后金属催化系统
- 批准号:
2247667 - 财政年份:2023
- 资助金额:
$ 27.56万 - 项目类别:
Standard Grant
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in at-risk Older Adults
同时进行有氧运动和认知训练可预防高危老年人的阿尔茨海默病
- 批准号:
10696409 - 财政年份:2023
- 资助金额:
$ 27.56万 - 项目类别:
Precision Medicine in Alzheimer’s Disease: A SMART Trial of Adaptive Exercises and Their Mechanisms of Action Using AT(N) Biomarkers to Optimize Aerobic-Fitness Responses
阿尔茨海默病的精准医学:使用 AT(N) 生物标志物优化有氧健身反应的适应性运动及其作用机制的 SMART 试验
- 批准号:
10581973 - 财政年份:2023
- 资助金额:
$ 27.56万 - 项目类别:
MIND Foods and Aerobic Training in Black Adults with HTN: An ADRD Prevention Pilot RCT (MAT)
MIND 食品和患有 HTN 的黑人成人的有氧训练:ADRD 预防试点随机对照试验 (MAT)
- 批准号:
10585366 - 财政年份:2023
- 资助金额:
$ 27.56万 - 项目类别:
Investigating the physical and chemical controls on aerobic methane oxidation
研究好氧甲烷氧化的物理和化学控制
- 批准号:
2241873 - 财政年份:2023
- 资助金额:
$ 27.56万 - 项目类别:
Standard Grant
Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training; a phase 2, double-blind, randomized placebo-controlled trial (PRIMiNG-AT2)
有氧训练中促进神经血管增益的炎症介质的消除;
- 批准号:
485524 - 财政年份:2023
- 资助金额:
$ 27.56万 - 项目类别:
Operating Grants
Effect of aerobic exercise-induced sleep changes on arterial stiffness associated with postprandial hyperglycemia.
有氧运动引起的睡眠变化对与餐后高血糖相关的动脉僵硬度的影响。
- 批准号:
23K10645 - 财政年份:2023
- 资助金额:
$ 27.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
- 批准号:
10717825 - 财政年份:2023
- 资助金额:
$ 27.56万 - 项目类别:
The Effects of Aerobic Exercise on Cardiovascular Health in Postmenopausal Females: A Systematic Review and Meta-Analysis
有氧运动对绝经后女性心血管健康的影响:系统评价和荟萃分析
- 批准号:
480729 - 财政年份:2023
- 资助金额:
$ 27.56万 - 项目类别: